| Pandemics throughout history J Piret, G Boivin Frontiers in microbiology 11, 631736, 2021 | 661 | 2021 |
| Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management J Piret, G Boivin Antimicrobial agents and chemotherapy 55 (2), 459-472, 2011 | 600 | 2011 |
| Antiviral drug resistance in herpesviruses other than cytomegalovirus J Piret, G Boivin Reviews in medical virology 24 (3), 186-218, 2014 | 172 | 2014 |
| In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses J Piret, J Lamontagne, J Bestman-Smith, S Roy, P Gourde, A Désormeaux, ... Journal of clinical microbiology 38 (1), 110-119, 2000 | 167 | 2000 |
| Modified cyclodextrins as broad-spectrum antivirals ST Jones, V Cagno, M Janeček, D Ortiz, N Gasilova, J Piret, M Gasbarri, ... Science advances 6 (5), eaax9318, 2020 | 157 | 2020 |
| Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management J Piret, G Boivin Current opinion in infectious diseases 29 (6), 654-662, 2016 | 148 | 2016 |
| Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses J Piret, A Désormeaux, MG Bergeron Current drug targets 3 (1), 17-30, 2002 | 147 | 2002 |
| Viral interference between respiratory viruses J Piret, G Boivin Emerging infectious diseases 28 (2), 273, 2022 | 139 | 2022 |
| Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational … JP Montenez, F Van Bambeke, J Piret, R Brasseur, PM Tulkens, ... Toxicology and applied pharmacology 156 (2), 129-140, 1999 | 108 | 1999 |
| DNA vaccination protects mice against Zika virus-induced damage to the testes BD Griffin, K Muthumani, BM Warner, A Majer, M Hagan, J Audet, ... Nature communications 8 (1), 15743, 2017 | 102 | 2017 |
| Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. MB Carlier, I Garcia-Luque, JP Montenez, PM Tulkens, J Piret International journal of tissue reactions 16 (5-6), 211-220, 1994 | 93 | 1994 |
| Herpesvirus DNA polymerases: Structures, functions and inhibitors K Zarrouk, J Piret, G Boivin Virus research 234, 177-192, 2017 | 92 | 2017 |
| Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance J Piret, G Boivin Antiviral research 163, 91-105, 2019 | 82 | 2019 |
| Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity F Van Bambeke, JP Montenez, J Piret, PM Tulkens, PJ Courtoy, ... European journal of pharmacology 314 (1-2), 203-214, 1996 | 68 | 1996 |
| Immunomodulatory strategies in herpes simplex virus encephalitis J Piret, G Boivin Clinical Microbiology Reviews 33 (2), 10.1128/cmr. 00105-19, 2020 | 63 | 2020 |
| Innate immune response during herpes simplex virus encephalitis and development of immunomodulatory strategies J Piret, G Boivin Reviews in medical virology 25 (5), 300-319, 2015 | 54 | 2015 |
| Thermoreversible Gel Formulations Containing Sodium Lauryl Sulfate or n-Lauroylsarcosine as Potential Topical Microbicides against Sexually Transmitted Diseases S Roy, P Gourde, J Piret, A Désormeaux, J Lamontagne, C Haineault, ... Antimicrobial agents and chemotherapy 45 (6), 1671-1681, 2001 | 52 | 2001 |
| Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics—I: Biochemical analysis MP Mingeot-Leclercq, J Piret, R Brasseur, PM Tulkens Biochemical pharmacology 40 (3), 489-497, 1990 | 52* | 1990 |
| Comparative Study of Mechanisms of Herpes Simplex Virus Inactivation by Sodium Lauryl Sulfate and n-Lauroylsarcosine J Piret, S Roy, M Gagnon, S Landry, A Désormeaux, RF Omar, ... Antimicrobial Agents and Chemotherapy 46 (9), 2933-2942, 2002 | 49 | 2002 |
| Artesunate Demonstrates in vitro Synergism with Several Antiviral Agents against Human Cytomegalovirus E Drouot, J Piret, G Boivin Antiviral therapy 21 (6), 535-539, 2016 | 46 | 2016 |
Guy BoivinCHU de Québec and Laval UniversityVerified email at crchudequebec.ulaval.ca
